HomeNewsOpinionMC Pro Quick Take: Sun Pharma’s US sales outpace Dr Reddy’s, Cipla in Q3

MC Pro Quick Take: Sun Pharma’s US sales outpace Dr Reddy’s, Cipla in Q3

R. Sree Ram • January 31, 2024 / 16:15 IST

Sun Pharma’s specialty drugs business continue to grow at a brisk pace, helped by ramp-up of key products

Pharmaceutical industry

To read the full story,

Are you a PRO subscriber? Sign In

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts